Related Experiment Video

Updated: Aug 7, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Genes and pathways downstream of telomerase in melanoma metastasis

Sepideh Bagheri1, Mehdi Nosrati, Shang Li

  • 1Auerback Melanoma Research Laboratory, Cutaneous Oncology Program, Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA.

Proceedings of the National Academy of Sciences of the United States of America
|July 19, 2006
PubMed

Insights

Telomerase suppression reduced tumor invasion and metastasis by altering cell shape and energy pathways. This study reveals new mechanisms linking telomerase activity to tumor cell metabolism and melanin production.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Telomerase plays a role in tumor progression, but its precise mechanisms are not fully understood.
  • Understanding telomerase's function is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To investigate the mechanism by which telomerase promotes tumor invasion and metastasis.
  • To explore the effects of telomerase suppression on tumor cell morphology, metabolism, and melanin production.

Main Methods:

  • Stable, ribozyme-mediated suppression of mouse telomerase RNA.
  • Analysis of telomerase RNA expression, telomerase activity, and telomere length.
  • Gene expression profiling to assess changes in metabolic pathways.
  • Measurement of glucose consumption and lactate production.

Main Results:

  • Suppression of telomerase reduced tumor invasion and metastatic potential.
  • Reduced telomerase activity induced a more dendritic cell morphology with increased melanin content and tyrosinase expression.
  • Telomerase targeting down-regulated glycolytic pathway genes, decreasing glucose consumption and lactate production.

Conclusions:

  • Telomerase activity influences tumor cell morphology and metabolic pathways, potentially through modulation of the glycolytic pathway.
  • These findings reveal novel mechanisms by which telomerase promotes tumor invasion and metastasis.
  • Targeting telomerase may offer a therapeutic strategy for reducing cancer progression.

More Related Videos

Experimental Metastasis Assay08:28

Experimental Metastasis Assay

Published on: August 24, 2010

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...